← brief for 2026-10-04 · Slowing decline

Efficacy and safety of nafamostat mesylate injection in patients receiving continuous renal replacement therapy: A Meta-Analysis

Article No results yet Peer reviewed

Key takeaways

This is a meta-analysis, which is a type of review that combines results from many smaller studies. It looks at a drug called nafamostat mesylate for people on dialysis. However, this item does not have an abstract, so the specific results are not available here.

Who did this work

Bingjie Yao

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-03
https://doi.org/10.5281/zenodo.23121488